Corrigendum to "Optimization of a novel piperazinone series as potent selective peripheral covalent BTK inhibitors" [Bioorg. Med. Chem. Lett. 60 (2022) 128549]

Bioorg Med Chem Lett. 2022 Sep 15:72:128856. doi: 10.1016/j.bmcl.2022.128856. Epub 2022 Jun 18.

¹ Medicinal Chemistry, Biogen, 225 Binney Street, Cambridge, MA 02142, USA. Electronic address: bma_4@yahoo.com.
² Biophysics, Biogen, 225 Binney Street, Cambridge, MA 02142, USA.
³ Drug Metabolism & Pharmacokinetics, Biogen, 225 Binney Street, Cambridge, MA 02142, USA.
⁴ Bioassays & High-Throughput Screens, Biogen, 225 Binney Street, Cambridge, MA 02142, USA.
⁵ Chemical Biology & Proteomics, Biogen, 225 Binney Street, Cambridge, MA 02142, USA.
⁶ Translational Science, Biogen, 225 Binney Street, Cambridge, MA 02142, USA.
⁷ Multiple Sclerosis and Neurorepair Research, Biogen, 225 Binney Street, Cambridge, MA 02142, USA.
⁸ Medicinal Chemistry, Biogen, 225 Binney Street, Cambridge, MA 02142, USA.
⁹ Medicinal Chemistry, Biogen, 225 Binney Street, Cambridge, MA 02142, USA. Electronic address: Brian.Hopkins@Biogen.com.

No abstract available

Publication types